Welcome to chemicalbook!
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook > Product Catalogue >Biochemical Engineering >Inhibitors >protein tyrosine kinase >Dacomitinib (PF299804)

Dacomitinib (PF299804)

Dacomitinib (PF299804) Structure
  • ₹5000 - ₹14200
  • Product name: Dacomitinib (PF299804)
  • CAS: 1110813-31-4
  • MF: C24H25ClFN5O2
  • MW: 469.94
  • EINECS:-0
  • MDL Number:MFCD19443734
  • Synonyms:PF-00299804-03;PF-00299804;DacoMitinib (PF-00299804);DacoMitinib,PF299804;DacoMitinib (PF299804,PF-00299804);PF299804;DACOMITINIB;DacoMitinib (PF299804, PF299);(E)-N-(4-((3-chloro-4-fluorophenyl)aMino)-7-Methoxyquizolin-6-yl)-4-(piperidin-1-yl)but-2-eMide
2 prices
Selected condition:

Brand

  • TCI Chemicals (India)

Package

  • 50MG
  • 250MG
  • ManufacturerTCI Chemicals (India)
  • Product numberD5450
  • Product descriptionDacomitinib
  • Packaging50MG
  • Price₹5000
  • Updated2022-05-26
  • Buy
  • ManufacturerTCI Chemicals (India)
  • Product numberD5450
  • Product descriptionDacomitinib
  • Packaging250MG
  • Price₹14200
  • Updated2022-05-26
  • Buy
Manufacturer Product number Product description Packaging Price Updated Buy
TCI Chemicals (India) D5450 Dacomitinib 50MG ₹5000 2022-05-26 Buy
TCI Chemicals (India) D5450 Dacomitinib 250MG ₹14200 2022-05-26 Buy

Properties

Melting point :184-187°C
Boiling point :665.7±55.0 °C(Predicted)
Density :1.344
storage temp. :Refrigerator
solubility :DMSO (Slightly), Methanol (Slightly, Heated)
form :White solid.
pka :12.05±0.43(Predicted)
color :White to Pale Yellow
CAS DataBase Reference :1110813-31-4

Safety Information

Symbol(GHS): GHS hazard pictograms
Signal word: Warning
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
H302 Harmful if swallowed Acute toxicity,oral Category 4 Warning GHS hazard pictograms P264, P270, P301+P312, P330, P501
Precautionary statements:
P280 Wear protective gloves/protective clothing/eye protection/face protection.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

Description

Dacomitinib is a selective and irreversible inhibitor of EGFR. It is a drug candidate for the treatment of non-small cell lung carcinoma. It is current under the Phase III clinical trials. It also shows potential for the treatment of HER-2 amplified breast cancer cells lines that are resistant to trastuzumab and lapatinib. 

Related product price